금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
WTI rises to near $85.00 amid escalating US-Iran tensions
West Texas Intermediate (WTI) oil price extends its gains for the fourth consecutive day, trading ar...
5 Energy Stocks Cashing In On The New Energy Crunch
The Iran war has created an extraordinary earnings season for U.S. refiners. Brent crude has fallen ...
Australian Dollar reverses as Iran risks lift USD ahead of Fed minutes
The Aussie Dollar reversed its course against the Greenback on Tuesday as investors remain uncertain...
Burford Capital outlines deleveraging focus with $733M cash and $400M debt due within nearly 4 years
Japan JP Foreign Reserves dipped from previous $1287.5B to $1287.1B in July
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
THOUSAND OAKS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Latigo Biotherapeutics, Inc. (“Latigo”), a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicine ...
Lower Oil Prices Lend Support For The Gold Rally
Oil prices fell for a second week running thanks to optimism surrounding renewed U.S.-Iran diplomacy to reopen the Strait of Hormuz. U.S. President Donald Trump announced on Monday that talks between ...
Oil prices jump as Iran weighs ban of U.S. ships from Hormuz; Houthis attack Saudi forces in Yemen
Macom outlines Q4 FY 2026 revenue of $415M-$425M with adjusted EPS of $1.97-$2.03 as backlog hits record 1.6:1 book-to-bill
Alarm.com raises 2026 outlook to $754.4M SaaS revenue while targeting 21% adjusted EBITDA margin exiting 2027
Chinese Yuan: Bullish tone with upside tests against US Dollar – UOB
United Overseas Bank (UOB) analysts Quek Ser Leang and Lee Sue Ann note that USD/CNH is trading with a soft underlying tone, with scope for the Dollar to test support levels near 6.7420 in the short t ...
Review & Preview: Nothing Gold Can Stay
The Dow broke a five-day winning streak on Thursday, while the S&P 500 and Nasdaq Composite tripped on a selloff in software stocks.
Natera outlines $2.85B-$2.91B 2026 revenue outlook backed by 31% growth ex true-ups
Viatris raises 2026 outlook while targeting $500M peak sales for fast-acting meloxicam
Trevi outlines 200+ global trial sites as it targets FDA alignment for non-IPF-ILD chronic cough in H2 2026